Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

 
 
BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

Alzheimer's Disease Research
Current Award

Dr. Jessisca W. Wu

Jessica W. Wu, Ph.D.

Columbia University Medical Center, Taub Institute for Alzheimer's Disease Research
New York, NY, United States

Title: Conformation-Dependent Uptake and Secretion Of Tau
Non-Technical Title: Identifying the Mechanism By Which Misfolded Tau Is Secreted and Taken Up In Neurons

Mentor:
Karen Duff, Ph.D.
Columbia University Medical Center

Duration: July 1, 2012 - June 30, 2014
Award Type: Research Fellowship
Award Amount: $100,000

Summary:

The tau protein is important for maintaining neuronal health in the central nervous system. When tau is misfolded, it accumulates and becomes a key pathological feature in Alzheimer's disease and frontotemporal dementia. Dr. Jessica Wu and her colleagues have determined that misfolded tau is taken up in neurons. This project aims to document how misfolded tau is released from neurons and is then subsequently taken up by surrounding neurons to spread pathology in diseases.

Details:

This project studies the spread of “tauopathology” in Alzheimer's disease and frontotemporal dementia with focuses on identifying the release and uptake of misfolded tau aggregates in neurons.  These experiments are investigating the mechanisms by which specific types of misfolded tau are taken up in neurons and whether these specific tau-types might share common uptake mechanisms.  Once inside the cell, the study also examines the fate of these tau aggregates. Specifically, Dr. Jessica Wu is examining whether the aggregates will be released in the axons of the neurons, then re-absorbed by surrounding neurons, or whether these are retained and degraded within the neuron.

One of the most innovative aspects of the study is the use of microfluidic chambers to investigate uptake, transport, and secretion of tau from specific parts of the cell. The chambers, which are roughly the size of the neuron itself, allow the separation of irrelevant portions of the cell from the axons being studied, which lie in the grooves that connect the chambers of neighboring cells. Identifying whether tau conformers are transported, in which direction they are transported, and whether they are released from axonal terminals is only made possible by use of such microfluidic chamber.  Recent data have suggested that tau might propagate between cells in living tissue. However, the findings have been contentious due to technical limitations of the previous experimental systems.  This approach seeks to definitively address the question of whether tau can propagate between cells, potentially spreading to nearby cells and allowing Alzheimer’s disease to spread throughout the brain.

Investigator Biography:

Dr. Jessica Wu is a postdoctoral scientist at the Taub Institute for Alzheimer’s Disease Research at the Columbia University Medical Center in New York City. She completed her doctoral studies at University of California, Irvine. Wu is trained in biochemical and structural analysis of amyloid protein misfolding in the neurodegenerative disease field. Her study focuses on elucidating the molecular mechanisms involved in the propagation of tauopathy in Alzheimer's disease.